BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 22369283)

  • 1. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model.
    He J; Wang Y; Sun S; Yu M; Wang C; Pei X; Zhu B; Wu J; Zhao W
    Nephrology (Carlton); 2012 Jul; 17(5):493-500. PubMed ID: 22369283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-vesicles derived from bone marrow stem cells protect the kidney both in vivo and in vitro by microRNA-dependent repairing.
    He J; Wang Y; Lu X; Zhu B; Pei X; Wu J; Zhao W
    Nephrology (Carlton); 2015 Sep; 20(9):591-600. PubMed ID: 25907000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model.
    Cavaglieri RC; Martini D; Sogayar MC; Noronha IL
    Transplant Proc; 2009 Apr; 41(3):947-51. PubMed ID: 19376395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
    Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
    Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J; Meng L; Li S; Qu L; Li X
    Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model.
    Sangidorj O; Yang SH; Jang HR; Lee JP; Cha RH; Kim SM; Lim CS; Kim YS
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F325-35. PubMed ID: 20484299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvesicles from Mesenchymal Stem Cells Overexpressing MiR-34a Ameliorate Renal Fibrosis In Vivo.
    Wang Y; Hu P; Li Y; Dong R; He J
    Iran J Kidney Dis; 2024 Mar; 18(2):99-107. PubMed ID: 38660698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
    Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
    Benchetrit S; Yarkoni S; Rathaus M; Pines M; Rashid G; Bernheim J; Bernheim J
    Isr Med Assoc J; 2007 Jan; 9(1):30-4. PubMed ID: 17274353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mesenchymal stem cells transplanted at different time points in a rat remnant kidney model.
    Bian X; Zhang B; Guo W; Liu N; Bai Y; Miao J; Zhao G; Liu B; Wang S; Ma L; Zheng L; Zhao Y; Li D; Feng J
    Am J Nephrol; 2014; 39(1):75-84. PubMed ID: 24457259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protects against ischemia/reperfusion-induced acute kidney injury.
    Tsuda H; Yamahara K; Otani K; Okumi M; Yazawa K; Kaimori JY; Taguchi A; Kangawa K; Ikeda T; Takahara S; Isaka Y
    Cell Transplant; 2014; 23(7):889-99. PubMed ID: 23562186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease.
    Wang Y; Lu X; He J; Zhao W
    Stem Cell Res Ther; 2015 May; 6(1):100. PubMed ID: 25998259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD44-hyaluronic acid interaction in exogenous mesenchymal stem cells homing to rat remnant kidney.
    Bian XH; Zhou GY; Wang LN; Ma JF; Fan QL; Liu N; Bai Y; Guo W; Wang YQ; Sun GP; He P; Yang X; Su XS; Du F; Zhao GF; Miao JN; Ma L; Zheng LQ; Li DT; Feng JM
    Kidney Blood Press Res; 2013; 38(1):11-20. PubMed ID: 24503496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model.
    Semedo P; Correa-Costa M; Antonio Cenedeze M; Maria Avancini Costa Malheiros D; Antonia dos Reis M; Shimizu MH; Seguro AC; Pacheco-Silva A; Saraiva Camara NO
    Stem Cells; 2009 Dec; 27(12):3063-73. PubMed ID: 19750536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.
    Alfarano C; Roubeix C; Chaaya R; Ceccaldi C; Calise D; Mias C; Cussac D; Bascands JL; Parini A
    Cell Transplant; 2012; 21(9):2009-19. PubMed ID: 22525800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effects of metanephric mesenchymal cells on acute renal tubular damage: experiment with rats].
    Zhou JF; Yuan FH; Li N; Yu J; Zhang YQ; Hou WP
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):534-9. PubMed ID: 18649769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lineage-negative bone marrow cells protect against chronic renal failure.
    Alexandre CS; Volpini RA; Shimizu MH; Sanches TR; Semedo P; di Jura VL; Câmara NO; Seguro AC; Andrade L
    Stem Cells; 2009 Mar; 27(3):682-92. PubMed ID: 19096042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of clusterin expression worsens renal ischemia-reperfusion injury.
    Zhou W; Guan Q; Kwan CC; Chen H; Gleave ME; Nguan CY; Du C
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F568-78. PubMed ID: 20007348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation.
    Li Y; Xue WJ; Tian PX; Ding XM; Yan H; Pan XM; Feng XS
    Transplant Proc; 2009 Jun; 41(5):1565-9. PubMed ID: 19545680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mesenchymal stem cells and darbepoetin improve ischemia-induced acute kidney injury outcomes.
    Altun B; Yilmaz R; Aki T; Akoglu H; Zeybek D; Piskinpasa S; Uckan D; Purali N; Korkusuz P; Turgan C
    Am J Nephrol; 2012; 35(6):531-9. PubMed ID: 22653289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.